Stay updated on Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page has been updated to include information about the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with new publications related to a specific clinical study. Additionally, several outdated dates and revision numbers have been removed.
    Difference
    5%
    Check dated 2025-05-29T06:04:39.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T14:22:15.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page has been updated to include the term 'Merkel Cell Carcinoma' and a new identifier for the study, while significant details about the study's design and inclusion/exclusion criteria have been removed.
    Difference
    31%
    Check dated 2025-04-16T10:59:19.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding a new date of December 31, 2024.
    Difference
    0.5%
    Check dated 2025-04-09T05:15:22.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:30:32.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:22:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.